title: Prophylactic use of deferiprone (L1) and magnetic resonance imaging T2* or T2 for preventing heart disease in thalassaemia.
authors.forename: Annita
authors.initials: A
authors.lastname: Kolnagou
authors.forename: Charis
authors.initials: C
authors.lastname: Fessas
authors.forename: Antonis
authors.initials: A
authors.lastname: Papatryphonas
authors.forename: Charalambos
authors.initials: C
authors.lastname: Economides
authors.forename: George J
authors.initials: GJ
authors.lastname: Kontoghiorghes
mesh_terms: D009202:Cardiomyopathies / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control*; D000077543:Deferiprone; D006801:Humans; D007502:Iron Chelating Agents / Q000008:administration & dosage*; D008279:Magnetic Resonance Imaging; D009206:Myocardium / Q000378:metabolism; D011728:Pyridones / Q000008:administration & dosage*; D013789:Thalassemia / Q000150:complications / Q000378:metabolism
chemical_list: D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone